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ABSTRACT: Fourteen new withanolides, 1−14, named
withalongolides A−N, respectively, were isolated from the
aerial parts of Physalis longifolia together with eight known
compounds (15−22). The structures of compounds 1−14
were elucidated through spectroscopic techniques and
chemical methods. In addition, the structures of withanolides
1, 2, 3, and 6 were confirmed by X-ray crystallographic
analysis. Using a MTS viability assay, eight withanolides (1, 2, 3, 7, 8, 15, 16, and 19) and four acetylated derivatives (1a, 1b, 2a,
and 2b) showed potent cytotoxicity against human head and neck squamous cell carcinoma (JMAR and MDA-1986), melanoma
(B16F10 and SKMEL-28), and normal fetal fibroblast (MRC-5) cells with IC50 values in the range between 0.067 and 9.3 μM.
Classically defined withanolides are a group of C28ergostane-type steroids with a C-22,26 δ-lactone group,
first isolated from the genus Withania.1 They are present
primarily in the Solanaceae family, which includes the genera
Acnistus, Datura, Dunalia, Jaborosa, Nicandra, Physalis, and
Withania.2−9 Withanolides have attracted interest in recent
years mainly due to their exhibition of significant biological
activities, inclusive of antimicrobial, antitumor, anti-inflamma-
tory, immunomodulatory, and insect-antifeedant activities.2,3,6
It has been reported that those withanolides displaying the
most promising antitumor characteristics contain an α,β-
unsaturated ketone in ring A, a 5β,6β-epoxy group in ring B,
and a nine-carbon side chain with an α,β-unsaturated δ-lactone
group.10 The typical withanolide withaferin A (16) (Figure 1)
contains these three moieties and has been shown in vitro and
in vivo to suppress the growth of an array of tumor cells,
including breast, pancreatic, prostate, lung, leukemia, and head
and neck squamous cell carcinoma (HNSCC), by inducing
apoptosis,11 thus possessing potential application as an
antiproliferative agent. As part of an ongoing study of
withanolides from plant sources,11,12 a library of 224 native
plant extracts from the U.S. Great Plains was evaluated for
cytotoxic activities against HNSCC and melanoma cell lines
using the MTS viability assay. One of the most promising leads,
Physalis longifolia Nutt. (Solanaceae), commonly known as
“long leaf groundcherry”, was subjected to a phytochemical
investigation, and the results are presented herein, including the
details of the isolation and structure elucidation of 14 new
withanolides (1−14), four acetylated derivatives (1a, 1b, 2a,
and 2b), and eight known compounds (15−22). Their
cytotoxicity was determined against HNSCC (JMAR and
MDA-1986), melanoma (B16F10 and SKMEL-28), and normal
fetal fibroblast (MRC-5) cells. This constitutes the first report
of a phytochemical and bioactivity study of P. longifolia.
■ RESULTS AND DISCUSSION
The CH2Cl2−MeOH (1:1) extract of the aerial parts of the title
plant and the EtOAc-soluble and n-BuOH-soluble fractions
showed cytotoxicity against the above-mentioned cells with
IC50 values in the range between 0.7 and 9.8 μg/mL using a
MTS assay. All compounds (1−22) were isolated from the
EtOAc-soluble or n-BuOH-soluble fractions (see Experimental
Section).
Compound 1 was isolated as colorless cuboid crystals
obtained from a CH2Cl2−CH3CN mixture, a major metabolite
in the EtOAc-soluble fraction. Its molecular formula, C28H38O7,
was determined by HRESIMS and NMR experiments, equating
to 10 double-bond equivalents. Its IR absorptions revealed the
presence of hydroxy (3431 and 3233 cm−1), keto (1671 cm−1),
and ester (1706 cm−1) groups. The 1H NMR spectrum (Table 1)
showed the presence of three methyl groups at δ 0.60 (3H, s),
0.90 (3H, d, J = 6.6 Hz), and 1.97 (3H, s), seven protons
attached to oxygenated carbons at δ 3.18 (1H, brs), 3.52 (1H,
d, J = 6.1 Hz), 3.65 (1H, d, J = 9.6 Hz), 4.17 (1H, d, J = 9.6
Hz), 4.23 (1H, d, J = 12.5 Hz), 4.28 (1H, d, J = 12.5 Hz), and
4.33 (1H, dt, J = 13.3, 3.4 Hz), and two olefinic methine groups
at δ 6.16 (1H, d, J = 10.0 Hz) and 6.95 (1H, dd, J = 10.0, 6.1
Hz). The 13C NMR (APT) and HSQC spectra for 1 (Table 2)
displayed 28 carbon signals differentiated as three CH3, eight
CH2 (including two oxygenated at δ 61.0 and 56.7), 10 CH
(including two olefins at δ 145.7 and 132.9, three oxygenated at
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δ 78.8, 68.0, and 61.8), and seven C (including one keto
carbonyl at δ 200.7, one ester carbonyl at δ 167.4, two olefins at
δ 154.3 and 125.6, and one oxygenated at δ 61.5), corresponding
to C28H35. The remaining three hydrogen atoms were therefore
assigned to three OH groups, indicating that six rings must be
present in the structure.
The NMR data of 1 were very close to those obtained for
withaferin A 16,1,13 a six-ring withanolide isolated as another
major compound in this study (Tables 1−3 and Figure 1).
Compound 1 was found to contain the following moieties also
observed in 16: an α,β-unsaturated ketone in ring A ([13C: δ
200.7 (C-1), 132.9 (C-2), 145.7 (C-3); 1H: δ 6.16 (H-2, d, J =
10.0 Hz), 6.95 (H-3, dd, J = 10.0, 6.1 Hz)]; an epoxy group in
ring B [13C: δ 61.5 (C-5), 61.8 (C-6); 1H: δ 3.18 (brs, H-6)];
and a nine-carbon side chain with an α,β-unsaturated δ-lactone
group [13C: δ 78.8 (C-22), 154.3 (C-24), 125.6 (C-25), 167.4
(C-26); 1H: δ 4.33 (H-22, dt, J = 13.3, 3.4 Hz)]), as supported
by 1H−1H COSY and HMBC experiments. The obvious
differences between 1 and 16 were the presence of an
oxygenated methylene [C-19, 13C: δ 61.0; 1H: δ 3.65 (1H, d,
J = 9.6 Hz), 4.17 (1H, d, J = 9.6 Hz)] in 1 and a methyl carbon
[C-19, 13C: δ 17.6; 1H: 1.38 (3H, s)] in the latter, suggesting
that 1 is a 19-hydroxy derivative of 16. This observation was
supported by the high-frequency shift of C-10 (δ 54.3 in 1 and
δ 47.9 in 16), the low-frequency shifts of C-1 (δ 200.7 in 1 and
δ 202.5 in 16), C-5 (δ 61.5 in 1 and δ 64.1 in 16), and C-9 (δ
43.9 in 1 and δ 44.3 in 16) in the 13C NMR spectra, and the
HMBC correlations between H2-19 [3.65 (1H, d, J = 9.6 Hz),
4.17 (1H, d, J = 9.6 Hz] and C-1, C-5, C-9, and C-10.
Acetylation of 1 with acetic anhydride in pyridine gave two
derivatives, the 4,19,27-triacetate (1a) and the 4,27-diacetate
(1b) (Tables 1 and 2), which proved the presence of hydroxy
groups at C-4, C-19, and C-27 by a high-frequency shift of H-4
(from δ 3.52 in 1 to δ 4.79 in 1a and to δ 4.73 in 1b), of H2-19
(from δ 3.65, 4.17 in 1 to δ 4.32, 5.07 in 1a), and of H2-27 (δ
4.23, 4.28 in 1 to δ 4.84, 4.88 in 1a and to δ 4.85, 4.88 in 1b)
and by HMBC correlations between H-4 and the ester
carbonyl, between H2-27 and the ester carbonyl, and between
H2-19 and the ester carbonyl in 1a and 1b.
Finally, the structure of 1 was confirmed through a single-
crystal X-ray diffraction experiment (Figure 2). Thus, 1
(withalongolide A) was established as 19-hydroxywithaferin
A. The full assignments of NMR data of 1, measured in CDCl3
with a trace amount of CD3OD and in C5D5N (Tables 1
Figure 1. Withanolides 1−21 and rutin (22) isolated from Physalis longifolia.
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and 2), were obtained by 2D-NMR methods including 1H−1H
COSY, HSQC, HMBC, and ROESY spectra.
Compound 2 was isolated as colorless rod crystals from a
CH2Cl2−CH3C6H5 mixture and was also a major metabolite
from the EtOAc-soluble part. Its molecular formula, C28H38O6,
was determined by HRESIMS and NMR experiments. The IR
and NMR (1H and 13C) data (Tables 1 and 2) were similar to
those of 1. Analysis of the 1D- and 2D-NMR data for 2
identified resonances consistent with an α,β-unsaturated ketone
in ring A [13C: δ 200.2 (C-1), 133.1 (C-2), 145.4 (C-3); 1H: δ
6.23 (H-2, d, J = 10.4 Hz), 7.01 (H-3, dd, J = 10.4, 6.4 Hz)], an
epoxy in ring B [13C: δ 61.7 (C-5), 62.1 (C-6); 1H: δ 3.25 (brs,
H-6)], a nine-carbon side chain with a δ-lactone group [13C: δ
78.4 (C-22), 149.2 (C-24), 122.2 (C-25), 167.3 (C-26); 1H: δ
4.31 (H-22, dt, J = 13.3, 3.4 Hz)], and an oxygenated C-19
[13C: δ 62.1; 1H: δ 4.32, 3.77 (d, J = 9.7 Hz)]. The obvious
differences between 2 and 1 were the presence of a 27-methyl
carbon [13C: δ 12.7; 1H: 1.85 (3H, s)] in 2 and an oxygenated
methylene [C-27, 13C: δ 56.7; 1H: δ 4.28 (1H, d, J = 12.5 Hz),
4.23 (1H, d, J = 12.5 Hz)] in 1, suggesting that 2 is a 27-deoxy
derivative of 1. This observation was supported by the 13C
NMR chemical shift values of the δ-lactone moiety [δ 149.2
(C-24), 122.2 (C-25), 167.3 (C-26) in 2 and δ 154.3 (C-24),
125.6 (C-25), 167.4 (C-26) in 1], by the NMR data comparison
of the side chain moiety of 2 to those of 27-deoxywithanolides,14,15
and by HMBC correlations of H3-27/C-24, C-25, and C-26.
Acetylation of 2 with acetic anhydride in pyridine yielded
the 4,19-diacetate (2a) and the 4-monoacetate (2b) (Tables 1
and 2), which confirmed the presence of hydroxy groups at C-4
and C-19 by a high-frequency shift of H-4 (from δ 3.63 in 2 to
δ 4.79 in 2a and to δ 4.74 in 2b) and H2-19 (from δ 3.77, 4.32
in 2 to δ 4.32, 5.07 in 2a).
Finally, the structure of 2 was confirmed through a single-
crystal X-ray diffraction experiment (Figure 3). Thus, 2
(withalongolide B) was determined as 27-deoxy-19-hydrox-
ywithaferin A.
Compound 3 was isolated as colorless cube crystals from a
CH2Cl2−CH3CN mixture, a minor component from the
EtOAc-soluble fraction. Its molecular formula, C28H38O7, was
determined by HRESIMS and NMR experiments. The NMR
data of 3 (Tables 1 and 2) were also akin to those of withaferin
A, 16.1,13 Analysis of the 1D- and 2D-NMR data of 3 identified
resonances consistent with an α,β-unsaturated ketone in ring A
[13C: δ 204.0 (C-1), 131.6 (C-2), 143.2 (C-3); 1H: δ 6.22 (H-2,
d, J = 10.0 Hz), 6.96 (H-3, dd, J = 10.0, 6.5 Hz)], an epoxy in
ring B [13C: δ 64.5 (C-5), 63.0 (C-6); 1H: δ 3.23 (brs, H-6)],
and a nine-carbon side chain with a δ-lactone group [13C: δ
78.9 (C-22), 153.0 (C-24), 125.9 (C-25), 167.2 (C-26); 1H: δ
4.39 (H-22, dt, J = 13.2, 3.5 Hz)]. The obvious differences
Table 1. 1H NMR Data for Withanolides 1, 1a, 1b, 2, 2a, 2b, and 3 (400 or 500 MHz)
pos. 1a 1b 1ac 1bc 2c 2ac 2bc 3c
2 6.16 d (10.0) 6.46 d (10.0) 6.23 d (10.0) 6.21 d (10.0) 6.23 d (10.4) 6.23 d (9.9) 6.23 d (9.9) 6.22 d (10.0)










7.00 dd (9.9, 6.0) 7.01 dd (9.9,
6.0)
6.96 dd (10.0, 6.5)
4 3.52 d (6.1) 4.01 d (6.1) 4.79 d (6.1) 4.73 d (6.1) 3.63 d (6.4) 4.79 d (6.0) 4.74 d (6.0) 3.78 d (6.5)
6 3.18 brs 3.42 brs 3.12 brs 3.20 brs 3.25 brs 3.16 brs 3.20 brs 3.23 brs
7 2.14 m, 1.25 m 2.15 ddd (2.2,
4.0, 14.5)
2.15 m 2.01 m, 1.96 m 2.19 ddd (2.2,
4.2, 15.0)




1.25 m 1.30 m 1.25 ddd (1.4,
11.3, 15.0)
1.28 m 1.29 m




1.85 m 1.51 dq (4.2,
11.1)
1.76 dq (4.2, 11.3) 1.85 m 1.87 dq (4.5, 10.8)
9 0.85 m 1.15 m 1.00 m 0.91 m 0.94 m 1.00 m 0.92 m 1.25 dd (3.3, 10.8)
11 1.90 m, 1.32 m 2.31 m, 1.55 m 1.96 m, 1.62 m 1.94 m, 1.85 m 1.94 m, 1.39 m 1.96 m, 1.62 m 1.94 m, 1.84 m 4.15 (brs)
12 1.86 m, 0.95 m 1.82 m, 0.99 m 1.97 m, 1.08 m 1.96 m, 1.05 m 1.93 m, 1.01 m 1.97 m, 1.08 m 1.98 m, 1.05 m 2.17 dd (13.8, 2.8),
1.38 m
14 0.81 m 0.83 m 0.87 m 0.83 m 0.85 m 0.86 m 0.85 m 0.92 m
15 1.57 m, 1.05 m 1.49 m, 0.92 m 1.62 m, 1.14 m 1.58 m, 1.13 m 1.61 m, 1.12 m 1.61 m, 1.12 m 1.61 m, 1.12 m 1.64 m, 1.22 m
16 1.59 m, 1.29 m 1.49 m, 1.12 m 1.67 m, 1.36 m 1.65 m, 1.36 m 1.65 m, 1.35 m 1.66 m, 1.36 m 1.65 m, 1.36 m 1.63 m, 1.37 m
17 0.99 m 0.99 m 1.07 m 1.05 m 1.04 m 1.07 m 1.06 m 1.04 m
18 0.60 s 0.53 s 0.73 s 0.73 s 0.66 s 0.72 s 0.73 s 0.90 s
19 4.17 d, 3.65 d
(9.6)
4.79 d, 4.21 d
(9.4)
5.07 d, 4.32 d
(11.5)
4.36 d, 4.07 d
(11.5)
4.32 d, 3.77 d
(9.7)
5.07 d, 4.32 d
(11.5)
4.37 d, 4.09 d
(11.6)
1.63 s
20 1.91 m 1.88 m 2.00 m 1.98 m 1.95 m 1.96 m 1.96 m 1.99 m
21 0.90 d (6.6) 0.95 d (6.7) 0.98 d (6.7) 0.97 d (6.6) 0.95 d (6.6) 0.97 d (6.6) 0.97 (6.6) 1.00 d (6.6)










4.31 dt (13.3, 3.4) 4.32 dt (13.3,
3.4)
4.39 dt (13.2, 3.5)














2.47 dd (13.2, 17.0)
1.91 m 2.17 m 1.99 m 2.16 m 1.87 m 1.88 m 1.88 m 1.94 dd (3.5, 17.0)
27 4.28 d, 4.23 d
(12.5)
4.86 d, 4.76 d
(11.8)
4.88 d, 4.84 d
(11.8)
4.88 d, 4.85 d
(11.9)
1.85 s 1.85 s 1.85 s 4.34 br
28 1.97 s 2.11 s 2.05 s 2.04 s 1.90 s 1.91 s 1.90 s 2.01 s
4-OAc 2.09 s 2.07 s 2.09 s 2.08 s
19-OAc 2.06 s 2.06 s
27-OAc 2.03 s 2.02 s
aIn CDCl3 with trace amount of CD3OD.
bIn C5D5N.
cIn CDCl3.
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between 3 and 16 were the presence of an oxygenated methine
[C-11, 13C: δ 69.5; 1H: 4.15 (1H, brs)] in 3 and a low-
frequency methylene [C-11, 13C: δ 22.3; 1H: δ 1.27 (1H, m),
1.18 (1H, m)] in 16, implying that 3 is 11-hydroxywithaferin A.
This observation was supported by the high-frequency shift of
C-9 (δ 48.1 in 3 and δ 44.3 in 16) and C-12 (δ 47.8 in 3 and δ
39.5 in 16) and the low-frequency shift of C-8 (δ 27.0 in 3 and
δ 29.9 in 16) in the 13C NMR spectrum; by the presence of the
fragment −CH2−CH(OH)−CH−CH(CH2)−CH− (starting
with C-12 and ending with C-14) deduced from 1H−1H COSY
and HSQC experiments; and by the HMBC correlations
between Hα-12 (δ 2.17, dd, J = 13.8, 2.8 Hz) and C-9 (δ 48.1),
C-11 (δ 69.5), C-13 (δ 42.1), and C-14 (δ 58.2). The
orientation of the hydroxy group at C-11 was deduced as β due
to the broad single-peak pattern of H-11 (δ 4.15, brs), the small
coupling constant of 3.3 Hz between H-9 (δ 1.25, dd, J = 10.8,
3.3 Hz) and H-11, and ROESY correlations of H-11/H-9 and
H-11/Hα-12. Finally, the structure of 3 was confirmed through
a single-crystal X-ray diffraction experiment (Figure 4). Thus,
Table 3. 1H NMR Data for Withanolides 4−7 and 16−19 (400 or 500 MHz)
pos. 4a 5a 6a 7b 16a 17a 18b,c 19b
2 Hβ 2.86 dd
(8.3, 16.4)
Hβ 2.86 dd (6.5,
17.5)
5.93 d (6.4) Hβ 3.65 dd
(8.1, 18.0)
6.18 d (10.0) Hβ 2.99 dd (6.3,
15.0)










Hα 2.56 dd (2.2,
15.0)




3 3.70 ddd (8.3,
3.4, 2.6)
3.75 ddd (6.5, 4.0,
2.2)




4.67 br 5.62 ddd (9.7,
6.5, 2.0)
4 3.42 d (3.4) 3.56 d (4.0) 4.54 br 3.74 d (5.9) 3.46 d (3.2) 4.05 br 4.51 br
6 3.22 brs 3.15 brs 5.76 t (3.5) 3.37 brs 3.21 s 3.19 s 3.30 br 3.62 br
7 2.25 m 2.31 dd (5.2, 14.8) 2.37 ddd (3.5,
8.8, 15.0)







1.42 m 1.34 m 1.70 m 2.11 m 1.30 m 1.31 m 1.40 ddd (2.0,
10.2, 15.0)
1.23 m
8 1.41 m 1.70 dq (4.5, 10.8) 1.75 m 1.50 m 1.39 m 1.39 m 1.50 m 1.41 m
9 1.14 m 1.28 m 1.17 m 1.16 m 1.14 m 1.16 m 1.17 m 1.04 m
11 1.27 m, 1.18 m 3.88 m 2.24 m, 1.58 m 1.57 m, 1.34 m 1.27 m, 1.18 m 1.35 m 1.52 m 1.44 m
12 1.90 m, 1.02 m 2.15 dd (13.9,
2.4), 1.38 m
1.99 m, 1.18 m 1.76 m, 1.02 m 1.88 m, 1.08 m 1.88 m, 1.08 m 1.85 m, 1.05 m 1.80 m, 1.05 m
14 0.95 m 0.94 m 1.03 m 0.91 m 0.95 m 0.94 m 0.93 m 0.92 m
15 1.64 m, 1.13 m 1.66 m, 1.21 m 1.61 m, 1.19 m 1.52 m, 0.90 m 1.64 m, 1.13 m 1.61 m, 1.12 m 1.54 m, 0.96 m 1.54 m, 0.92 m
16 1.66 m, 1.35 m 1.64 m, 1.38 m 1.64 m, 1.35 m 1.57 m, 1.13 m 1.66 m, 1.35 m 1.64 m, 1.31 m 1.54 m, 1.15 m 1.57 m, 1.15 m
17 1.07 m 1.04 m 1.10 m 1.13 m 1.07 m 1.05 m 1.07 m 1.14 m
18 0.62 s 0.85 s 0.75 s 0.47 s 0.67 s 0.64 s 0.55 s 0.52 s
19 4.38 d, 3.61 d
(10.2)
1.49 s 1.15 s 4.80 d, 4.01 d
(9.4)
1.38 s 1.28 s 1.76 s 1.69 s
20 1.96 m 1.99 m 1.99 m 1.86 m 1.97 m 1.97 m 1.90 m 1.90 m
21 0.95 d (6.7) 1.00 d (6.7) 1.01 d (6.6) 0.95 d (6.6) 0.97 d (6.6) 0.96 d (6.6) 0.97 d (6.6) 0.97 d (6.6)
22 4.39 dt (13.2,
3.5)






























1.94 dd (3.2, 17.8) 1.98 dd (3.2,
17.6)







27 4.36 d, 4.32 d
(12.5)
4.37 d, 4.31 d
(12.6)
4.37 d, 4.32 d
(12.5)
4.85 d, 4.75 d
(11.7)
4.36 d, 4.31 d
(12.6)
4.36 d, 4.31 d
(12.6)
4.80 d, 4.78 d
(11.8)
4.85 d, 4.75 d
(11.7)
28 2.02 s 2.01 s 2.01 s 2.09 s 2.01 s 2.01 s 2.10 s 2.09 s
3-OMe 3.35 s 3.34 s 3.32 s
aIn CDCl3.
bIn C5D5N.
cOH-4 signal 7.75 s, OH-3 signal 6.91 brs, OH-27 signal 6.61 brs.
Figure 2. X-ray ORTEP drawing of withalongolide A (1).
Figure 3. X-ray ORTEP drawing of withalongolide B (2).
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the new withanolide 3 (withalongolide C) was established as
11β-hydroxywithaferin A.
Compounds 4 and 5 were isolated as two presumed artifacts.
These two compounds were probably formed from with-
alongolide A (1) and withalongolide C (3), respectively, by a
Michael-type addition due to the use of CH3OH during the
extraction procedure. It is possible that these compounds are
formed in a similar fashion to 2,3-dihydro-3β-methoxywithafer-
in A (17)1 (Tables 2 and 3), which was most likely derived
from withaferin A (16) during this study. Comparing the NMR
data of the methoxy group in 17 [−OCH3 group at C-3: 1H: δ
3.32 (3H, s); 13C: δ 57.0; H-3: δ 3.68 (1H, ddd, J = 6.3, 3.2, 2.2
Hz); C-3: δ 77.7] with both 4 and 5 [−OCH3: 1H: δ 3.35 (3H,
s); 13C: δ 57.6; H-3: δ 3.70 (1H, ddd, J = 8.3, 3.4, 2.6 Hz); C-3:
δ 77.7 in 4 and −OCH3: 1H: δ 3.34 (3H, s); 13C: δ 57.4; H-3: δ
3.75 (1H, ddd, J = 6.5, 4.0, 2.2 Hz); C-3: δ 76.2 in 5] suggested
the presence of a methoxy group at the C-3 positions in 4
and 5. This was confirmed by the presence of a 1H−1H COSY
fragment of −CH2−CH(OCH3)−CH(OH)− in ring A and
HMBC correlation of OCH3/C-3 in both 4 and 5. The
structures of 4 (withalongolide D) and 5 (withalongolide E)
were determined by spectroscopic methods, and complete
assignments of their NMR data are listed in Tables 2 and 3.
Compound 6 was isolated as colorless cube crystals obtained
from a CH2Cl2−CH3CN mixture. Its molecular formula,
C27H34O4, was ascertained by HRESIMS and NMR experi-
ments (Tables 2 and 3). Similar to withaferin A (16), it showed
signals for four methyl groups [13C: δ 20.2 (C-28), 19.9 (C-19),
13.6 (C-21), 12.1 (C-18); 1H: δ 2.01 (H3-28, s), 1.15 (H3-19,
s), 1.01 (H3-21, d, J = 6.6 Hz), 0.75 (H3-18, s)], an α,β-
unsaturated ketone in ring A [13C: δ 211.6 (C-1), 129.4 (C-2),
155.2 (C-3); 1H: δ 5.93 (H-2, d, J = 6.4 Hz), 7.57 (H-3, d, J =
6.4 Hz)], and a nine-carbon side chain with an α,β-unsaturated
δ-lactone group [13C: δ 57.7 (C-27), 79.0 (C-22), 153.1 (C-
24), 125.9 (C-25), 167.3 (C-26); 1H: δ 4.42 (H-22, dt, J = 13.3,
3.4 Hz), 4.37 (H-27, d, J = 12.5 Hz), 4.32 (H-27, d, J = 12.5)].
A detailed comparison of the NMR data of 6 to those of 16
indicated that both compounds share identical ring C, D and
side chain moieties, but are different in their A and B rings.
A five-membered ring A for 6 was proposed on the basis of the
following evidence: (1) the unusual chemical shift value of the
conjugated ketone carbon (C-1, δ 211.6); (2) the coupling
pattern of H-3 (δ 7.57, d, J = 6.4 Hz) and the small coupling
constant of 6.4 Hz between the olefinic protons H-2 and H-3
when compared to those of H-3 (6.91, dd, J = 10.0, 5.9 Hz) in
16, showing C-3 to be linked with a quaternary carbon in 6.
This five-membered ring A and a C-5,6 double bond in ring B
were supported by the HMBC correlations of H3-19/C-1, C-5
(quaternary carbon, δ 147.4), C-9 (δ 42.8), and C-10 (δ 47.6);
of H-2/C-1, C-3, C-5, and C-10; and of H-3/C-1, C-2, C-5, C-6
(methine, δ 123.8), and C-10. Finally, the observation was
confirmed through a single-crystal X-ray diffraction experiment
(Figure 5). Thus, 6 (withalongolide F) was deduced to be
A-nor-27-hydroxy-1-oxowitha-2,5,24-trienolide. This 4-norwi-
thanolide with a 2,5-dien-1-one system was reported previously
as a semisynthetic product derived from withaferin A by an
acid-catalyzed rearrangement.16
Compound 7 was a major compound isolated from the
BuOH-soluble fraction. Its molecular formula, C28H40O11S, was
determined by HRESIMS and NMR experiments. The NMR
data of 7 (Tables 2 and 3) were similar to those of 2,3-dihydro-
3β-O-sulfate-withaferin A (19) (Tables 2 and 3),17 another
major withanolide isolated from the BuOH-soluble fraction
during this study (Figure 1). The obvious differences between 7
and 19 were the presence of an oxygenated methylene [C-19,
13C: δ 59.9; 1H: δ 4.80 (1H, d, J = 9.4 Hz), 4.01 (1H, d, J = 9.4
Hz)] in 7 and a methyl carbon [C-19, 13C: δ 15.9; 1H: δ 1.69
(3H, s)] in the latter, suggesting that 7 is a 19-hydroxy
derivative of 19. This observation was supported by the high-
frequency shift of C-10 (δ 55.7 in 7 and δ 49.9 in 19), the low-
frequency shift of C-1 (δ 208.0 in 7 and δ 209.7 in 19), C-5
(δ 63.0 in 7 and δ 65.1 in 19), and C-9 (δ 42.3 in 7 and
δ 43.1 in 19) in the 13C NMR spectrum, and the HMBC
correlations of H2-19 [δ 4.01 (1H, d, J = 9.4 Hz), 4.80 (1H, d,
J = 9.4 Hz]/C-1, C-5, C-9, and C-10 in 7. Thus, 7 (withalongo-
lide G) was determined as 2,3-dihydro-19-hydroxy-3β-O-sulfate-
withaferin A.
Compound 8 was isolated as a major component from the
BuOH-soluble fraction. Its molecular formula, C40H58O15, was
ascertained by HRESIMS and NMR experiments. The NMR
data of 8 (Tables 4 and 5) showed similarities to those of 27-O-
β-D-glucopyranosylwithaferin A (15) (sitoindoside IX)18
(Tables 4 and 5) isolated during this study, suggesting 8 to
be a withanolide saponin. The aglycone of 8 was determined to
be withaferin A, as both 8 and 15 possess the superimposable
1H and 13C NMR signals of the steroid aglycone moieties and
both showed the same main LC-MS/MS fragments of m/z 471
and 281 due to the presence of a withaferin A moiety. Differing
in the presence of only one glucose residue in 15, two sugar
residues were observed in 8 on the basis of the signals of two
anomeric carbons [methines, δ 105.3 (C-1′) and 103.1 (C-1″)]
and their corresponding anomeric protons [δ 4.97 (H-1′, 1H, d,
J = 7.8) and 5.94 (H-1″, 1H, s)]. Furthermore, the data for 8
suggested that the compound had, besides a glucose unit, an
additional five oxygenated carbons (five methines) and one
low-frequency methyl group [13C: δ 19.0; 1H: δ 1.74 (3H, d,
Figure 4. X-ray ORTEP drawing of withalongolide C (3).
Figure 5. X-ray ORTEP drawing of withalongolide F (6).
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J = 6.1 Hz)], corresponding to a rhamnose in the pyranose form.
The rhamnose moiety was deduced by the detailed comparison
of the NMR data of 8 with those of rutin 22 {3-O-[α-L-
rhamnopyranosyl-(1→6)]-β-D-glucopyranosylquercetin} also
isolated in this study and confirmed from the 1H−1H COSY,
HSQC, and HMBC spectra when starting with the character-
istic methyl group [C-6″, 13C: δ 19.0; 1H: δ 1.74 (3H, d, J = 6.1
Hz)]. The α-anomeric configuration of the rhamnose unit was
assigned from the small coupling constant between H-1″ (1H, δ
5.94, s) and H-2″ (1H, δ 4.73, s). Furthermore, the rhamnose
Table 4. 1H NMR Data for Withanolides 8−15 in C5D5N (500 MHz)
pos. 8a 9b 10c 11d 12e 13f 14g 15h
1 4.61 m Hα 2.74 m, Hβ
2.10 m




7.14 d (7.7) 3.01 dd (7.1, 15.5) 2.94 dd (8.1,
15.2)
Hα 1.96 m, Hβ
1.80 m
6.43 d (10.0)




2.91 dd (3.7, 15.5) 2.91 dd (4.1,
15.2)
3 7.25 dd (10.0,
6.3)
4.29 m 4.84 m 7.34 t (7.7) 4.58 m 4.47 m 4.33 br 7.25 dd (10.0,
6.3)
4 4.05 dd (6.3,
3.8)
Hβ 3.07 dt (2.0,
12.2)
Hβ 2.95 t (12.5) 7.87 d (7.7) 3.63 td (3.2, 18.0) 2.68 dd (5.9,
16.8)
Hα 2.90 d (15.8) 4.05 dd (6.3,
3.7)




2.92 m 2.58 td (2.7,
16.8)
Hβ 2.81 dd (2.2,
15.8)
6 3.28 s 5.75 brd (5.3) 5.92 brd (4.5) 5.26 dt (11.0,
6.5)
4.69 m Hα 2.26 m, Hβ
2.09 m
3.28 s
7 2.13 dt (13.0,
1.8)
1.92 m, 1.53 m Hα 1.66 dd
(11.0, 16.0)






Hβ 2.02 m 2.32 dd (6.5,
11.0)
2.00 m 1.30 dd (11.5,
13.0)
8 1.58 m 1.74 dt (5.3, 10.7) 2.20 m 1.73 q (11.0) 1.48 m 1.24 m 1.62 m 1.57 m
9 1.06 m 1.94 m 2.32 m 2.71 t (11.0) 2.20 m 2.04 m 1.86 m 1.06 m
11 2.02 m, 1.57 m 2.37 m, 1.96 m 2.15 m, 1,98 m 3.68 m, 1.46 m 2.96 m, 1.17 m 2.80 m, 2.34 m 1.84 m, 1.24 m 2.02 m, 1.57 m
12 1.83 m, 1.03 m 1.95 m, 1.26 m 1.95 m, 1.02 m 1.95 m, 1.30 m 1.83 m, 1.17 m 1.82 m, 1.13 m 1.85 m, 1.03 m 1.85 m, 1.02 m
14 0.86 m 0.97 m 0.86 m 1.10 m 0.95 m 0.90 m 0.88 m 0.86 m
15 1.50 m, 0.96 m 1.50 m, 1.02 m 1.49 m, 1.06 m 1.52 m, 1.12 m 1.45 m, 1.02 m 1.44 m, 1.02 m 1.33 m, 0.88 m 1.50 m, 0.95 m
16 1.49 m, 1.11 m 1.50 m, 1.14 m 1.91 m, 1.24 m 1.98 m, 1.27 m 1.95 m, 1. Twenty-
three m
1.95 m, 1.23 m 1.91 m, 1.21 m 1.49 m, 1.11 m
17 0.99 m 1.05 m 1.04 m 1.12 m 1.07 m 1.07 m 1.06 m 0.99 m
18 0.57 s 0.67 s 0.80 s 0.70 m 0.59 s 0.58 s 0.50 s 0.57 s





20 1.88 m 1.90 m 1.98 m 2.01 m 1.96 m 1.96 m 1.96 m 1.88 m
21 0.96 d (6.6) 0.97 d (6.6) 0.99 d (6.6) 1.01 d (6.6) 0.97 d (6.6) 0.96 d (6.6) 0.99 d (6.6) 0.95 d (6.6)
22 4.34 m 4.40 dt (13.2, 3.4) 4.25 m 4.55 dt (13.2,
3.4)






23 2.27 dd (13.3,
18.0)
2.34 dd (18.0, 14.0) 2.78 m, 2.33 m 2.83 dd (18.0,
2.2)


















27 5.02 d, 4.80 d
(10.8)
4.88 d, 4.78 d
(11.0)
2.04 s 2.05 s 2.05 s 2.05 s 2.06 s 5.07 d, 4.86 d
(10.8)
28 2.07 s 2.14 s 4.87 d, 4.49 d
(13.5)
4.89 d, 4.47 d
(13.5)
4.89 d, 4.49 d
(13.5)
4.89 d, 4.49 d
(13.5)
4.90 d, 4.50 d
(13.5)
2.10 s
1′ 4.97 d (7.8) 5.08 d (7.8) 4.84 d (7.8) 4.84 d (7.8) 4.84 d (7.8) 4.84 d (7.8) 4.85 d (7.8) 5.06 d (7.8)
2′ 4.01 td (7.8,
3.6)
4.05 t (7.8) 4.10 m 4.10 m 4.10 m 4.10 m 4.11 dd (7.8,
7.0)
4.08 t (7.8)
3′ 4.23 m 4.30 m 4.25 m 4.25 m 4.25 m 4.25 m 4.25 m 4.31 m
4′ 4.51 t (9.0) 4.31 m 4.24 m 4.24 m 4.24 m 4.24 m 4.24 m 4.30 m
5′ 3.75 ddd (2.5,
5.0, 9.0)
3.97 ddd (2.5, 5.0,
9.0)
3.99 m 4.00 m 4.00 m 4.00 m 4.00 m 4.00 ddd (2.5,
5.6, 9.0)
6′ 4.31 m, 4.16 m 4.54 ddd (2.5, 5.0,
11.6)
4.62 m 4.62 ddd (2.0,
5.6, 11.6)








4.42 td (5.0, 11.6) 4.42 m 4.42 td (5.6,
11.6)






aH-1″ 5.94 s, H-2″ 4.73 s, H-3″ 4.60 br, H-4″ 4.38 dd (4.1, 9.9), H-5″ 5.06 m, H-6″ 1.74 d (6.1), OH-4 7.87 d (3.8), OH-2′ 7.36 d (3.5), OH-2″ 6.84 s,
OH-4″ 6.83 s, OH-3′ 6.83 s, OH-6″ 6.82 m, OH-3″ 6.55 d (5.5). bOH-2′ 7.27 s, OH-19 7.27 d (3.9), OH-6′ 6.56 t (5.0), OH-27 6.49 brs. cOH-2′
7.51, OH-3′ 7.36 s, OH-4′ 7.24 s, OH-6′ 6.52 t (5.0), OH-3 6.20 d (5.0), OH-1 5.97 d (5.0), OH-19 5.96 brs. dOH-1 11.33 s, OH-2′ 7.45 d (4.5),
OH-3′ 7.35 brs, OH-4′ 7.25 brs, OH-6 6.81 d (6.5), OH-6′ 6.53 t (5.6). eOH-2′ 7.54 d (4.3), OH-3′ 7.34 brs, OH-4′ 7.26 brs, OH-6 6.93 d (6.5), OH-
3 6.84 (4.0), OH-6′ 6.53 t (5.6). fOH-2′ 7.54 d (4.2), OH-3′ 7.34 brs, OH-4′ 7.26 brs, OH-3 6.81 d (4.1), OH-6′ 6.53 t (5.5). gOH-2′ 7.49 brs, OH-3′
7.38 brs, OH-4′ 7.28 brs, OH-6′ 6.53 t (5.6), OH-3 6.28 brs. hOH-4 7.86 d (3.7), OH-3′ 7.22 brs, OH-4′ 7.28 brs, OH-2′ 7.21 brs, OH-6′ 6.47 t (5.6),
OH-3 6.28 brs.
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was confirmed to be attached at C-4′ (δ 78.5) on the basis of
HMBC correlations of H-1″/C-4′ and H-4′/C-1″, also
supported by the glycosylation shifts of C-4′ (δ 78.5 in 8 and
δ 72.1 in 15), C-3′ (δ 77.1 in 8 and δ 79.0 in 15), and C-5′
(δ 77.8 in 8 and δ 79.1 in 15). Thus, the structure of 8
(withalongolide H) was determined as 27-O-[α-L-rhamno-
pyranosyl(1→4)]-β-D-glucopyranosylwithaferin A.
Compounds 9−14 were isolated as the minor components
from the BuOH-soluble fraction. Withanolide 9 was assigned a
molecular formula of C34H50O11 by HRESIMS and NMR
experiments. Its NMR data (Tables 4 and 5) exhibited a close
resemblance to those of withalongolide A (1), possessing the
same nine-carbon side chain with an α,β-unsaturated δ-lactone,
identical rings C and D, and an oxygenated C-19 methylene
group. In addition, the remaining rings A and B showed
similarities to those of 3-O-β-D-glucopyranosyl-20,27-dihy-
droxy-1-oxowitha-5,24-dienolide, a withanolide saponin re-
ported from Physalis peruviana,19 with the following signals:
(1) the occurrence of a ketone (δ 208.9, C-1) and a double
bond [13C: C-5 quaternary carbon, δ 132.8, and C-6 methine, δ
129.1; 1H: δ 5.75 (1H, brd, J = 5.3 Hz, H-6)]; (2) a glucose
moiety attached to C-3 in ring A [13C: δ 75.9 (CH, C-3);
characteristic signals for glucose: δ 103.5 (CH, C-1′), 79.1 (CH,
C-5′), 79.1 (CH, C-3′), 75.6 (CH, C-2′), 71.9 (CH, C-4′), and
63.0 (CH2, C-6′)]; (3) a fragment of −CH2−CH(O)−CH2−
in ring A deduced from the 1H−1H COSY and HSQC spectra;
(4) HMBC correlations of H-3/C-1′ and H-1′/C-3; of H2-19/
C-1, C-5, C-9, and C-10; of H2-2/C-1, C-3, C-4, and C-10; and
of Hβ-4/C-2,C-3, C-5, C-6, and C-10. Thus, the structure of 9
(withalongolide I) was determined as 3-O-β-D-glucopyranosyl-
19,27-dihydroxy-1-oxo-witha-5,24-dienolide.
Compound 10 was assigned a molecular formula of
C34H52O11 by HRESIMS and NMR experiments. Similar to
those of 9, the NMR data of 10 (Tables 4 and 5) displayed the
presence of an oxygenated C-19 methylene group [13C: δ 63.9
CH2;
1H: δ 4.32 (1H, d, J = 11.0 Hz), 4.11 (1H, d, J = 11.0
Hz)] and three methyl groups [13C: δ 12.6, 13.0, 14.1; 1H: δ
0.80 (s), 0.99 (d, J = 6.6 Hz), 2.04 (s)]. The obvious differences
between 10 and 9 were the presence of an oxygenated methine
(δ 69.5) in 10 instead of the keto carbon (C-1, δ 208.9) in 9,
implying that a hydroxy group is attached to C-1. This was
supported by the presence of a 1H−1H COSY fragment of
−CH(O)−CH2−CH(O)−CH2− assigned as a C-1 to C-4
moiety in ring A and confirmed by HMBC correlations of H2-
19/C-1, C-5, C-9, and C-10 and of H2-4/C-2, C-3, C-5, C-6,
and C-10. The orientation of the hydroxy group at C-1 was
assigned as α on the basis of the small coupling constant of H-1
(δ 4.61, s)/H2-2. Furthermore, it was determined that the
Table 5. 13C NMR Data for Withanolides 8−15 in C5D5N (125 MHz)
pos. 8a 9 10 11 12 13 14 15
1 203.1 208.9 69.5 157.8 199.4 198.3 25.6 203.1
2 132.8 49.6 41.7 115.1 49.4 49.7 30.6 132.8
3 145.6 75.9 66.6 127.4 66.3 66.1 64.7 145.6
4 70.8 39.9 44.4 119.3 36.9 41.9 32.9 70.8
5 65.0 132.8 137.8 146.2 156.4 153.6 130.4 65.0
6 60.6 129.1 127.0 70.7 71.2 33.8 198.6 60.6
7 32.2 31.9 32.6 38.3 37.3 26.4 44.0 32.2
8 30.7 33.5 33.8 39.0 37.5 39.9 40.0 30.7
9 45.1 43.6 42.4 46.6 44.3 43.6 46.6 45.1
10 49.0 60.2 48.2 127.8 136.5 136.1 158.7 49.0
11 22.2 24.1 22.3 27.1 26.4 26.6 25.1 22.2
12 39.9 40.6 40.7 41.5 41.0 41.0 40.2 39.9
13 43.1 43.5 43.6 44.2 43.9 44.1 43.3 43.1
14 56.5 57.0 57.5 54.9 54.2 54.9 54.8 56.5
15 24.9 25.0 25.2 24.7 24.5 24.5 24.0 24.9
16 27.6 27.6 27.8 27.7 27.6 27.7 27.5 27.6
17 52.4 52.5 52.6 52.9 52.7 52.7 52.3 52.4
18 12.0 12.5 12.6 12.9 12.6 12.7 12.2 12.0
19 17.7 63.7 63.9 17.7
20 39.5 39.6 39.9 40.0 39.9 39.9 39.8 39.5
21 13.9 13.9 14.1 13.9 13.9 13.9 14.0 13.9
22 78.6 78.9 79.7 79.6 79.6 79.6 79.5 78.7
23 30.4 30.3 25.2 25.2 25.2 25.2 25.2 30.4
24 157.4 154.5 148.8 148.7 148.8 148.7 148.7 157.4
25 124.3 127.8 125.2 125.3 125.2 125.2 125.2 124.4
26 166.3 166.9 167.1 167.1 167.1 167.1 167.1 166.4
27 64.0 56.6 13.0 12.9 12.9 12.9 12.9 63.9
28 21.0 20.6 67.1 66.9 67.0 67.0 67.0 21.0
1′ 105.3 103.5 103.5 103.4 103.5 103.5 103.5 105.4
2′ 75.9 75.6 75.4 75.4 75.4 75.4 75.4 75.7
3′ 77.1 79.1 79.0 79.0 79.0 79.0 79.1 79.0
4′ 78.5 71.9 72.1 72.1 72.1 72.1 72.1 72.1
5′ 77.8 79.1 79.3 79.3 79.3 79.3 79.3 79.1
6′ 61.9 63.0 63.3 63.3 63.3 63.3 63.3 63.2
a1″ (103.1), 2″ (73.1), 3″ (73.3), 4″ (74.5), 5″ (70.8), 6″ (19.0).
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glucose was attached to C-28 by the HMBC correlations of H2-
28/C-23, 24, 25, 1′ and of H-1′/C-28, as well as the chemical
shifts of C-23 (δ 25.2), C-24 (δ 148.8), C-25 (δ 125.2), C-26
(δ 167.1), C-27 (δ 13.0), and C-28 (δ 67.1) and detailed
comparison to those of withanolides with a 28-O-glucoside
moiety.20 Thus, the structure of 10 (withalongolide J) was
determined as 28-O-β-D-glucopyranosyl-1α,3β,19-trihydroxywi-
tha-5,24-dienolide.
Similar to withalongolide J (10), compounds 11−14 were
shown to possess the same nine-carbon side chain with an α,β-
unsaturated δ-lactone and a glucose moiety at C-28, on the
basis of their superimposable NMR signals assigned to the side
chain (Tables 4 and 5).
Saponin 11 was assigned a molecular formula of C33H46O10
by HRESIMS and NMR experiments. Excluding the six carbons
corresponding to the glucose moiety, the 27-carbon aglycon
implied that one carbon in the C28 withanolide scaffold must be
lost. The NMR data of its aglycon were similar to those of
1,6,27-trihydroxy-19-norwitha-1,3,5(10),24-tetraenolide (a 19-
norwithanolide with an aromatic ring A).21 A trisubstituted
aromatic ring A in 11 was observed from the 1H NMR (H-2: δ
7.14, 1H, d, J = 7.7 Hz; H-3: δ 7.34, 1H, t, J = 7.7 Hz; and H-4:
δ 7.87, 1H, d, J = 7.7 Hz) and 13C NMR (C-1: δ 157.8 C; C-2:
δ 115.1, CH; C-3: δ 127.4 CH; C-4: δ 119.3 CH; C-5: δ 146.2
C; and C-10: δ 127.8, C) experiments. This was confirmed by
1H−1H COSY and HSQC experiments and HMBC correla-
tions of H-2/C-4 and C-10, H-3/C-1 and C-5, and H-4/C-2
and C-10. Moreover, the HMBC correlations of H-4/C-6 (δ
70.7 CH), of OH-6 (δ 6.81, d, J = 6.5 Hz)/C-5 and C-6, and of
H-7β/C-5 and the 1H−1H COSY fragment −CH(OH)−CH2−
CH−CH−CH2−CH2− (corresponding to −C6−C7−C8−C9−
C11−C12−) showed that both the aglycone of 16 and 1,6,27-
trihydroxy-19-norwitha-1,3,5(10),24-tetraenolide have the same
planar structural moieties in rings A and B. However, the
orientation of the hydroxy group at C-6 was assigned as α
because of the large coupling constants (11.0 Hz) between H-6
(δ 5.26, dt, J = 11.0, 6.5 Hz) and H-7α (δ 1.63, q, J = 11.0 Hz)
and (6.5 Hz) between H-6 and H-7β (δ 2.32, dd, J = 11.0, 6.5
Hz). Thus, the structure of 11 (withalongolide K) was
determined as 28-O-β-D-glucopyranosyl-1,6α-dihydroxy-19-
norwitha-1,3,5(10),24-tetraenolide.
Compound 12 was assigned a molecular formula of
C33H48O11 by HRESIMS and NMR experiments. Its NMR
data (Tables 4 and 5) were similar to those of withalongolide K
(11), containing the same rings B, C, and D because of their
superimposable 1H and 13C NMR signals. The differences
observed between 12 and 11 were caused by changes in the
ring A moiety. Unlike the aromatic ring A in 11, a conjugated
5(10)-en-1-one system in 12 was revealed by the chemical
shifts of quaternary carbons at δ 199.4 (C-1), 156.4 (C-5), and
136.5 (C-10). A 1H−1H COSY fragment of −CH2−CH-
(OH)−CH2− was assigned as −C2−C3−C4− in ring A and
confirmed by the HMBC correlations of H2-2/C-1, C-3, and
C-4 and of H2-4/C-2, C-5, and C-10. Thus, the structure of 12
(withalongolide L) was determined as 28-O-β-D-glucopyranosyl-
3β,6α-dihydroxy-1-oxo-19-norwitha-5(10),24-dienolide.
Compound 13 was assigned a molecular formula of
C33H48O10 by HRESIMS and NMR experiments. Its NMR
data were similar to those observed for withalongolide L (12),
containing a conjugated 5(10)-en-1-one system [13C: δ 198.3
(C-1), 153.6 (C-5), 136.1 (C-10)] in ring A. The obvious
difference between 13 and 12 was the presence of a methylene
(13C: δ 33.8; 1H: δ 2.30, 2H, m) instead of an oxygenated
methine (13C: δ 71.2; 1H: δ 4.69), suggesting that 13 is a
6-deoxy derivative of 12. This observation was supported by the
13C NMR high-frequency shift of C-4 (δ 41.9 in 13 and δ 36.9
in 12) and C-8 (δ 39.9 in 13 and δ 37.5 in 12), the low-
frequency shift of C-7 (δ 26.4 in 13 and δ 37.3 in 12), and
HMBC correlations of OH-3 (δ 6.81, 1H, d, J = 4.1 Hz)/C-2 (δ
49.7), C-3 (δ 66.1), and C-4 (δ 41.9), of H2-4 (δ 2.68, dd, J =
5.9, 16.8 Hz and δ 2.58, dd, J = 2.7, 16.8 Hz)/C-2, C-3, C-5
(δ 153.6), C-6 (δ 33.8), and C-10 (δ 136.1), and of H-6β
(δ 2.09, m)/C-4, C-5, C-7 (δ 26.4), C-8 (39.9), and C-10 in 13.
Thus, the structure of 13 (withalongolide M) was determined
as 28-O-β-D-glucopyranosyl-3β-hydroxy-1-oxo-19-norwitha-5-
(10),24-dienolide.
Compound 14 was assigned a molecular formula of
C33H48O10 by HRESIMS and NMR experiments and as an
isomer of withalongolide M (13). The NMR data of these two
compounds (Tables 4 and 5) were similar to each other, having
the same functional groups and the same multiplicities for all
other carbons present. A conjugated 5(10)-en-6-one system
[13C: δ 198.6 (C-6), 158.7 (C-10), 130.4 (C-5)] in 14 was
proposed instead of the 5(10)-en-1-one one in 13 on the basis
of the following observations: (1) a 1H−1H COSY fragment of
−CH2−CH2−CH(OH)−CH2− (from C-1 to C-4) in ring A of
14 replaced the ring A fragment −CH2−CH(OH)−CH2−
(from C-2 to C-4) in 13; (2) a 1H−1H COSY fragment of
−CH2−CH−CH− (from C-7 to C-9) in ring B of 14 replaced
the ring B fragment −CH2−CH2−CH−CH− (from C-6 to C-
9) in 13; (3) HMBC correlations of H-2/C-1 (δ 25.6), C-3
(δ 64.7), and C-4 (δ 32.9); of H2-7/C-5 (δ 130.4), C-6 (δ
198.6), C-8 (δ 40.0), and C-9 (δ 46.6); and of H-1/C-3, C-5,
and C-10 (δ 158.7). Furthermore, the orientation of the
hydroxy group at C-3 was determined as α due to the small
coupling constant (J = 2.2 Hz) between H-3 (δ 4.33, brs)/H-4β
(δ 2.81, dd, J = 2.2, 15.8 Hz) and the NOESY correlations
of H-3/H-1β, H-2β, and H-4β. Thus, the structure of 14
(withalongolide N) was assigned as 28-O-β-D-glucopyranosyl-
3α-hydroxy-6-oxo-19-norwitha-5(10),24-dienolide.
Eight known compounds were identified by comparison of
their data with those published in the literature, as seven
withanolides, sitoindoside IX (15),18 withaferin A (16),1,13 2,3-
dihydro-3β-methoxywithaferin A (17),15 viscosalactone B
(18),22 2,3-dihydro-3β-O-sulfate withaferin A (19),17 2,3-
dihydrowithaferin A (20),15 and 3α,6α-epoxy-4β,5β,27-trihy-
droxy-1-oxowitha-24-enolide (21),23 and a flavonoid glucoside,
rutin (22).24 The full assignments of the NMR data of 15, 16,
17, 18, and 19 are listed in Tables 2−5, as these data were
either unavailable, incomplete, or in need of revision within the
published literature.
The classically defined withanolide-type steroids (1−21)
isolated from the title plant showed a diversity of oxygena-
tion patterns that may be summarized as follows: (1) Six
withanolides (1, 2, 4, 7, 9, and 10) have an oxygenated C-19
group, which is rare in Nature. A literature investigation showed
that from the approximately 520 unmodified withanolides only
nine C-19 oxygenated withanolides have been reported so far.
They are as follows: jaborosalactones O,25 V, W, X,26 46, 47,
and 48,27 cinerolide,28 and bracteosin B.29 (2) Compounds 3
and 5 are rare examples of unmodified withanolides having an
oxygenated C-11, although withasomniferanolide (with an 11β-
OH group),30 somniferanolide (with an 11β-OH group),30 and
witharifeen (with an 11α-OH group)31 have been previously
reported. (3) Saponins 10−14 have a sugar constituent
attached at C-28. Only two previously published withanolide
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saponins (physagulins E and G)20 have been shown to have a
sugar moiety at C-28 thus far. (4) Compounds 11−14 are the
first reported examples of C-19 norwithanolide saponins. It
should be noted, however, that there are only four C-19
norwithanolides (jaborosalactones Q,21 7,32 and 45; 12-O-
methyljaborosalactone 4527) reported in the literature. (5)
Most withanolides have an oxygenated C-1 in ring A, but 15 is
the exception by not being oxidized at C-1. In addition, the
presence of a 3-O-sulfate group in naturally occurring
withanolides is extremely rare. Besides withanolides 7 and 19,
there are only five other 3-O-sulfate withanolides previously
reported from Datura metel,33 Solanum cilistum,34 and Withania
somnifera.35
All the withanolides (1−21) and the four acetylated deriva-
tives (1a, 1b, 2a, and 2b) were tested against the HNSCC
(JMAR, MDA-1986), melanoma (B16F10 and SKMEL-28),
and/or normal fetal fibroblast (MRC-5) cells for their
cytotoxicity. As summarized in Table 6, withanolides 1−5, 7,
8, 15, 16, and 19 and the four derivatives (1a, 1b, 2a, and
2b) showed cytotoxic effects against the cells tested with IC50
values in the range 0.067−9.3 μM, while the other withanolides
were inactive. Similar to withaferin A (16), withanolides 1−3,
containing the functional groups of a 2-en-1-one in ring A, a
5β,6β-epoxy in ring B, and a lactone ring in the side chain, were
active, showing the importance of these three groups. The
activity of the 3-O-sulfate withanolides 7 and 19 was due to
their transformations to 1 and 16, respectively. Withanolide
glycosides 8 and 15 displayed less cytotoxicity relative to their
aglycone withaferin A (16). However, the esterification of the
hydroxy groups at C-4, C-19, and C-27 increased the resultant
cytotoxicity, as shown for the acetylated derivatives 1a and 2a
with IC50 values less than 1 μM against all the cells tested.
These results are in agreement with previous structure−activity
relationship reports.10,36,37 In addition, it should be noted that
withalongolide A (1), withalongolide B (2), and withaferin A
(16) are most likely responsible for the cytotoxic activities of
the extract prepared from the title plant due to their relatively
high abundance levels (0.16% for 1, 0.10% for 16, and 0.03%
for 2).
■ EXPERIMENTAL SECTION
General Experimental Procedures. Melting points were
obtained using an MPA100 melting point apparatus. Optical rotations
were measured with a Rudolph RS Autopol IV automatic polarimeter.
IR data were obtained with a Thermo Nicolet Avatar 360 FT-IR
spectrometer. NMR spectra were recorded with a Bruker AV-400 or
AV-500 instrument with a cryoprobe for 1H, APT, COSY/DQF-
COSY, HSQC, HMBC, and NOESY/ROESY. Chemical shift values
are given in δ (ppm) using the peak signals of the solvent C5D5N (δH
8.74, 7.58, and 7.22; and δC 150.35, 135.91, and 123.87) or CDCl3 (δH
7.24 and δC 77.23) as references, and coupling constants are reported
in Hz. ESIMS data were measured with an Agilent 1200 Series LC-
MS/MS ion trap 6300 mass spectrometer. HRESIMS data were
collected with a LCT Premier time-of-flight mass spectrometer
(Waters Corp., Milford, MA, USA). Column chromatography was
performed on silica gel (particle size 12−25 μm) (Sorbent
Technologies, Atlanta, GA, USA), MCI CHP20P (particle size 75−
150 μm) (Sigma-Aldrich, Saint Louis, MO, USA), or Sephadex LH-20
(GE Healthcare, Piscataway, NJ, USA) or C18 reversed-phase silica gel
(particle size 40−65 μm) (Sigma-Aldrich). Normal-phase silica gel G
TLC plates (w/UV 254) and reversed-phase C18 TLC plates (w/UV
254) (Sorbent Technologies) were used for fraction detection. The
spots were visualized using UV light at 254 nm and spraying with 10%
EtOH−sulfuric acid reagent. Semipreparative HPLC was performed
on an Agilent 1200 unit equipped with a DAD detector, utilizing a
Lichrospher RP-18 column (250 × 10 mm, 5 μm).
Plant Material. Fresh aerial parts of the plant P. longifolia were
collected from the Kanopolis wildlife area (latitude: 38.74206°;
longitude: 97.98467°), Ellsworth County, Kansas, USA, in August
2009. It was identified by plant taxonomist Dr. Kelly Kindscher at the
Kansas Biological Survey, University of Kansas. A voucher specimen
(Hillary Loring 3583) was deposited in the R.L. McGregor Herbarium
of the University of Kansas.
Extraction and Isolation. The collected biomass was air-dried at
room temperature. The dried material was then ground to a coarse
powder (930 g) and extracted three times with CH2Cl2−MeOH (50:50,
4.0 L) at room temperature. After removing the solvents under vacuum,
the extract (107 g) was suspended in 400 mL of H2O, followed by
partitions with n-hexane, EtOAc, and n-butanol (3 × 500 mL). The
resulting ethyl acetate fraction (22 g) collected was applied to silica gel
flash CC (column chromatography) and eluted subsequently with
hexane−acetone mixtures of increasing polarities. The fraction obtained
on elution with hexane−acetone (80:20) (1.0 g) was again subjected to
silica gel CC [eluted with CH2Cl2−CH3COCH3 (90:10)] to afford
compound 2 (280 mg). The fraction (3.0 g) obtained on elution with
hexane−acetone (70:30) was subjected to silica gel CC [eluted with
CH2Cl2−CH3COCH3 (80:20)] to yield compounds 16 (730 mg), 17
(7 mg), and 20 (10 mg). The fraction (700 mg) obtained on elution
with hexane−acetone (65:35) was subjected further to silica gel CC
[eluted with hexane−acetone (65:35)] to afford compounds 3 (30 mg)
and 5 (5 mg). The fraction (2.2 g) acquired on elution with hexane−
acetone (60:40) was applied to silica gel CC [eluted with hexane−
acetone (60:40)] to afford compounds 1 (1200 mg) and 4 (15 mg).
The n-butanol fraction (29 g) obtained was subjected to a MCI
CHP20P gel CC (500 g) eluted with a mixture of H2O−MeOH (100:0,
80:20, 60:40, 40:60, 85:15, 0:100), in order of increasing concentrations
of methanol. The 85% MeOH fraction (3.5 g) was subjected to silica gel
CC, eluted with CH2Cl2−CH3COCH3 with increasing amounts of
acetone to afford compounds 1 (240 mg), 6 (40 mg), 16 (200 mg), 18
(250 mg), and 21 (220 mg). The 60% MeOH fraction (4.2 g) was
subjected to silica gel CC, eluted with CH2Cl2−MeOH-H2O (7:1:0.1)
with increasing amounts of MeOH−H2O (10:1). Then the fractions
were further subjected to reversed-phase C18 Si gel column
chromatography (200 g, particle size 40−63 μm), eluted by MeOH−
H2O (40:60, 50:50, 60:40, 65:35). The fractions obtained were
subjected to semipreparative HPLC, with the mobile phase CH3CN−
H2O (26:74; 28:72), to afford compounds 7 (40 mg), 8 (35 mg), 9 (9
mg), 10 (12 mg), 11 (6 mg), 12 (5 mg), 13 (6 mg), 14 (7 mg), 15 (22
mg), 19 (35 mg), and 22 (80 mg).
Table 6. Cytotoxicity (IC50) of Isolated Withanolides (μM)






1 >10 5.1 5.3 3.3 >10
1a 0.067 0.54 0.16 0.91 0.58
1b 0.098 0.81 0.14 2.2 0.41
2 0.20 3.9 0.17 1.3 0.40
2a 0.13 0.27 0.24 0.11 0.51
2b 0.19 0.64 0.12 0.49 0.16
3 0.49 3.0 0.77 2.6 3.6
4 3.2 9.3 4.7 >10 6.5
5 5.6 >10 >10 8.3 7.3
7 1.3 4.8 2.3 2.0 3.3
8 >10 >10 8.2 8.1 8.7
15 3.7 8.3 4.2 >10 5.2
16 0.29 4.0 2.0 0.80 0.20
19 0.18 5.1 0.48 0.27 1.4
cisplatin (positive control) 1.0 1.1 1.1 1.6 8.9
aFor cell lines used, see text. Withanolides 6, 9−14, 17, 18, 20, and 21
were inactive for all cell lines used (IC50 > 10 μM).
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Withalongolide A (1): colorless cuboid crystals (CH3CN); mp
216−217 °C; [α]25D +14.2 (c 0.16, CHCl3); IR (neat) νmax 3431 (br),
3233 (br), 2922, 1706, 1671, 1400, 1037, 962 cm−1; 1H NMR and 13C
NMR, see Tables 1 and 2; ESIMS (positive-ion mode) m/z 487 (M +
H, 6), 469 (M − H2O + H, 100), 451 (M − 2 H2O + H, 6);
HRESIMS m/z 509.2489 [M + Na]+ (calcd for C28H38O7Na,
509.2471), m/z 487.2674 [M + H]+ (calcd for C28H39O7,
487.2696), m/z 469.2585 [M − H2O + H]+ (calcd for C28H37O6,
469.2590).
Single-Crystal X-ray Structure Determination of Withalongolide
A (1). Crystal analysis was performed with a colorless plate crystal
(dimensions 0.42 × 0.35 × 0.21 mm3) obtained from CH2Cl2−
CH3CN (1:1) using Mo Kα radiation (λ = 0.71073 Å) on a Bruker
SMART APEX diffractometer equipped with a sealed-tube X-ray
source and a graphite monochromator. Crystal data for 1: C28H38O7
(formula weight 486.58), monoclinic, space group P21, T = 100(2) K,
crystal cell parameters a = 8.370(2) Å, b = 10.523(3) Å, c = 14.280(3)
Å, β = 104.552(4)°, V = 1217.4(5) Å3, Dc = 1.327 Mg/m
3, Z = 2,
F(000) = 524, absorption coefficient μ = 0.094 mm−1. A total of 11
335 reflections were collected in the range 2.43° < θ < 29.21°, with
5809 independent reflections [R(int) = 0.050] and 5478 with I > 2σ(I);
completeness to θmax was 93.1%. Multiscan absorption correction
applied; full-matrix least-squares refinement on F2, the numbers of
data/restraints/parameters were 5809/1/468; goodness-of-fit on F2 =
1.015; final R indices [I > 2σ(I)], R1 = 0.045, wR2 = 0.098; R indices
(all data), R1 = 0.048, wR2 = 0.099; largest difference peak and hole,
0.37 and −0.21 e/Å−3.
Acetylation of Withalongolide A (1). A solution of 1 (50 mg)
in pyridine (8 mL) and acetic anhydride (2 mL) was stirred for 24 h at
room temperature. Then 50 mL of water was added to the solution.
The precipitate (70 mg) was subjected to semipreparative HPLC,
eluted with the mobile phase CH3CN−H2O (45:55), to afford
triacetate 1a (40 mg) and diacetate 1b (10 mg).
Withalongolide A 4,19,27-triacetae (1a): IR (neat) νmax 2953
(br), 1731, 1702, 1674, 1366, 1208, 1023, 966 cm−1; 1H NMR and 13C
NMR, see Tables 1 and 2; ESIMS (positive-ion mode) m/z 630 (M +
H2O, 30), 613 (M + H, 100); HRESIMS m/z 635.2829 [M + Na]
+
(calcd for C34H44O10Na, 635.2832).
Withalongolide A 4,27-diacetae (1b): IR (neat) νmax 3536 (br),
2922, 1736, 1701, 1674, 1376, 1215, 1021, 967 cm−1; 1H NMR and
13C NMR, see Tables 1 and 2; ESIMS (positive-ion mode) m/z 1163
(2 M + Na, 6), 588 (M + H2O, 10), 571 (M + H, 100); HRESIMS
m/z 593.2740 [M + Na]+ (calcd for C32H42O7Na, 593.2727).
Withalongolide B (2): colorless plate crystals (toluene); mp 197−
198 °C; [α]25D +12.3 (c 0.15, CHCl3); IR (neat) νmax 3260 (br), 3006,
2946, 2887, 1693, 706, 1675, 1383, 1082, 763 cm−1; 1H NMR and 13C
NMR, see Tables 1 and 2; ESIMS (positive-ion mode) m/z 963
(2 M + Na, 40), 941 (2 M + H, 70), 493 (M + Na, 10), 471 (M + H, 4),
453 (M − H2O + H, 100), 435 (M − 2 H2O + H, 45%); HRESIMS
m/z 493.2554 [M + Na]+ (calcd for C28H38O6Na, 493.2566).
Single-Crystal X-ray Structure Determination of Withalongolide
B (2). Crystal analysis was performed with a colorless plate
(dimensions 0.21 × 0.16 × 0.15 mm3) obtained from CH2Cl2−
CH3COCH3−toluene (1:1:1) using Cu Kα radiation (λ = 1.54178 Å)
on a Bruker APEX2 diffractometer equipped with a Bruker MicroStar
microfocus rotating anode X-ray source and Helios multilayer optics.
Crystal data for 2: C28H38O6·C7H8 (formula weight 562.72),
orthorhombic, space group P212121, T = 100(2) K, crystal cell
parameters a = 7.1844(3) Å, b = 26.0678(10) Å, c = 49.0852(18) Å,
V = 9192.8(6) Å3, Dc = 1.220 Mg/m
3, Z = 12, F(000) = 3648, absorption
coefficient μ = 0.65 mm−1. A total of 32 032 reflections were collected
in the range 1.80° < θ < 69.15°, with 13 806 independent reflections
[R(int) = 0.035] and 12 653 with I > 2σ(I); completeness to θmax was
90.8%. Multiscan absorption correction applied; full-matrix least-squares
refinement on F2, the numbers of data/restraints/parameters were 13
806/0/1108; goodness-of-fit on F2 = 1.083; final R indices [I > 2σ(I)],
R1 = 0.096, wR2 = 0.233; R indices (all data), R1 = 0.102, wR2 = 0.238;
largest difference peak and hole, 0.84 and −0.32 e/Å−3.
Acetylation of Withalongolide B (2). A solution of 2 (50 mg)
in pyridine (8 mL) and acetic anhydride (2 mL) was stirred for 24 h at
room temperature. Then 50 mL of water was added to the solution.
The precipitate (65 mg) was subjected to semipreparative HPLC,
eluted with the mobile phase CH3CN−H2O (43:57), to afford
diacetate 2a (41 mg) and monoacetate 2b (11 mg).
Withalongolide B 4,19-diacetate (2a): IR (neat) νmax 2943 (br),
1738, 1698, 1368, 1220, 1127, 1043, 1019, 762 cm−1; 1H NMR and
13C NMR, see Tables 1 and 2; ESIMS (positive-ion mode) m/z 1109
(2 M + H, 60), 577 (M + Na, 40), 555 (M + H, 30), 495 (M −
HOAC + H, 100), 435 (M − 2 HOAC + H, 30), 296 (70); HRESIMS
m/z 577.2764 [M + Na]+ (calcd for C32H42O8Na, 577.2727).
Withalongolide B 4-acetate (2b): IR (neat) νmax 3536 (br), 2922,
1736, 1701, 1674, 1376, 1215, 1021, 967 cm−1; 1H NMR and 13C
NMR, see Tables 1 and 2; ESIMS (positive-ion mode) m/z 1047
(2 M + Na, 30), 1025 (2 M + H, 75), 513 (M + H, 100), 453 (M −
HOAc + H, 6); HRESIMS m/z 535.2670 [M + Na]+ (calcd for
C30H40O7Na, 535.2672).
Withalongolide C (3): colorless cuboid crystals, mp 197−198 °C;
[α]25D +10.3 (c 0.12, CHCl3); IR (neat) νmax 3550 (br), 3419 (br),
2952, 2879, 1686, 1663, 1394, 1227, 1026, 957 cm−1; 1H NMR and
13C NMR, see Tables 1 and 2; ESIMS (positive-ion mode) m/z 469
(M − H2O + H, 100); HRESIMS m/z 509.2481 [M + Na]+ (calcd for
C28H38O7Na, 509.2471).
Single-Crystal X-ray Structure Determination of Withalongolide
C (3). Crystal analysis was performed with a colorless irregular chunk
(dimensions 0.45 × 0.32 × 0.25 mm3) obtained from CH2Cl2−
CH3CN (1:1) and measured using Mo Kα radiation (λ = 0.71073 Å)
on a Bruker APEX diffractometer equipped with a sealed-tube X-ray
source and a graphite monochromator. Crystal data for 3: C28H38O7
(formula weight 486.58), orthorhombic, space group P212121, T =
100(2) K, crystal cell parameters a = 10.679(4) Å, b = 12.245(5) Å, c =
18.674(7) Å, V = 2442(2) Å3, Dc = 1.324 Mg/m
3, Z = 4, F(000) =
1048, absorption coefficient μ = 0.094 mm−1. A total of 22 352
reflections were collected in the range 2.53° < θ < 29.12°, with 6145
independent reflections [R(int) = 0.055] and 5925 with I > 2σ(I);
completeness to θmax was 95.6%. Multiscan absorption correction
applied; full-matrix least-squares refinement on F2, the numbers of
data/restraints/parameters were 6145/0/468; goodness-of-fit on F2 =
1.080; final R indices [I > 2σ(I)], R1 = 0.045, wR2 = 0.109; R indices
(all data), R1 = 0.046, wR2 = 0.113; largest difference peak and hole,
0.63 and −0.21 e/Å−3.
Withalongolide D (4): [α]25D +2.7 (c 0.08, CHCl3); IR (neat) νmax
3411 (br), 2944 (br), 1693, 1393, 1211, 1023 cm−1; 1H NMR and 13C
NMR, see Tables 2 and 3; ESIMS (positive-ion mode) m/z 1059
(2 M + Na, 6), 519 (M + H, 25), 501 (M − H2O + H, 100), 483 (M −
2 H2O + H, 4); HRESIMS m/z 541.2798 [M + Na]
+ (calcd for
C28H38O7Na, 541.2777).
Withalongolide E (5): [α]25D +2.2 (c 0.12, CHCl3); IR (neat) νmax
3550 (br), 2940 (br), 1690, 1390, 1200, 1020 cm−1; 1H NMR and 13C
NMR, see Tables 2 and 3; ESIMS (positive-ion mode) m/z 1059
(2 M + Na, 20), 541 (M + Na, 18), 501 (M −H2O + H, 100); HRESIMS
m/z 541.2777 [M + Na]+ (calcd for C28H38O7Na, 541.2777).
Withalongolide F (6): colorless cuboid crystals, mp 190−191 °C;
[α]25D +8.9 (c 0.16, CHCl3); IR (neat) νmax 2887, 1683, 1659, 1393,
1002, 851 cm−1; 1H NMR and 13C NMR, see Tables 2 and 3; ESIMS
(positive-ion mode) m/z 871 (2 M + Na, 25), 425 (M + H, 100);
HRESIMS m/z 447.2503 [M + Na]+ (calcd for C27H38O4Na,
447.2511).
Single-Crystal X-ray Structure Determination of Withalongolide
F (6). Crystal analysis was performed with a colorless rectangular
parallelepiped (dimensions 0.39 × 0.37 × 0.20 mm3) obtained from
CH2Cl2−CH3CN (1:1) and measured using Mo Kα radiation (λ =
0.71073 Å) on a Bruker APEX diffractometer equipped with a sealed-
tube X-ray source and graphite monochromator. Crystal data for 6:
C27H36O4 (formula weight 424.56), monoclinic, space group P21, T =
100(2) K, crystal cell parameters a = 10.873(5) Å, b = 9.233(4) Å, c =
12.271(6) Å, β = 113.273(7)°, V = 1132(9) Å3, Dc = 1.246 Mg/m
3,
Z = 2, F(000) = 460, absorption coefficient μ = 0.082 mm−1. A total of
10 347 reflections were collected in the range 2.85° < θ < 29.06°, with
5283 independent reflections [R(int) = 0.041] and 5133 with I > 2σ(I);
completeness to θmax was 93.8%. Multiscan absorption correction
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applied; full-matrix least-squares refinement on F2, the numbers of
data/restraints/parameters were 5283/1/424; goodness-of-fit on F2 =
1.055; final R indices [I > 2σ(I)], R1 = 0.045, wR2 = 0.107; R indices
(all data), R1 = 0.046, wR2 = 0.108; largest difference peak and hole,
0.43 and −0.21 e/Å−3.
Withalongolide G (7): [α]25D −2.3 (c 0.11, MeOH); IR (neat) νmax
3385 (br), 2950 (br), 1686, 1399, 1234, 992 cm−1; 1H NMR and 13C
NMR, see Tables 2 and 3; ESIMS (positive-ion mode) m/z 1031 [2
(M − SO3) + Na, 20], 585 (M + H, 50), 505 (M − SO3 + H, 100);
(negative-ion mode) m/z 583 (M − H, 100); HRESIMS m/z
607.2169 [M + Na]+ (calcd for C28H40O11SNa, 607.2189).
Withalongolide H (8): [α]25D −0.9 (c 0.12, MeOH); IR (neat) νmax
3369 (br), 2929 (br), 1686, 1398, 1018, 916 cm−1; 1H NMR and 13C
NMR, see Tables 4 and 5; ESIMS (positive-ion mode) m/z 796 [M +
H2O, 40], 471 (M − rha − glc + H, 100); LC-MS/MS fragments of
m/z 796 peak: m/z 471 (M − rha−glc + H, 100), 281 (10); LC-MS/
MS fragments of m/z 471 peak: m/z 281 (100); HRESIMS m/z
801.3683 [M + Na]+ (calcd for C40H58O15Na, 801.3673).
Withalongolide I (9): [α]25D −7.1 (c 0.08, MeOH); IR (neat) νmax
3381 (br), 2921 (br), 1686, 1398, 1007 cm−1; 1H NMR and 13C
NMR, see Tables 4 and 5; ESIMS (positive-ion mode) m/z 652 (M +
H2O, 6), 635 (M + H, 5), 473 (M − glc + H, 100); HRESIMS m/z
657.3267 [M + Na]+ (calcd for C34H50O11Na, 657.3251).
Withalongolide J (10): [α]25D −1.0 (c 0.13, MeOH); IR (neat)
νmax 3370 (br), 2931 (br), 1687, 1396, 1017 (br) cm
−1; 1H NMR and
13C NMR, see Tables 4 and 5; ESIMS (positive-ion mode) m/z 1273
(2 M + H, 100), 619 (M − H2O + H, 20), 601 (M − 2 H2O + H, 15),
583 (M − 3 H2O + H, 10), 475 (M − glc + H, 6); HRESIMS m/z
659.3411 [M + Na]+ (calcd for C34H52O11Na, 657.3407).
Withalongolide K (11): [α]25D +3.1 (c 0.17, MeOH); IR (neat)
νmax 3381 (br), 2921 (br), 1686, 1398, 1007 cm
−1; 1H NMR and 13C
NMR, see Tables 4 and 5; ESIMS (positive-ion mode) m/z 460 (M −
glc + H, 40) 603 (M + H, 35), 1205 (2 M + H, 100); HRESIMS m/z
625.33007 [M + Na]+ (calcd for C33H46O10Na, 625.2989).
Withalongolide L (12): [α]25D −3.1 (c 0.09, MeOH); IR (neat)
νmax 3350 (br), 2931 (br), 1687, 1396, 1018 cm
−1; 1H NMR and 13C
NMR, see Tables 4 and 5; ESIMS (positive-ion mode) m/z 1241
(2 M + H, 15), 1079 (2 M − glc + H, 30), 638 (M + H2O, 80). 459
(M − glc + H, 100); LC-MS/MS fragments of the m/z 638 peak: m/z
621 (M + H, 80), 459 (M − glc + H, 100); HRESIMS m/z 643.3101
[M + Na]+ (calcd for C33H48O11Na, 643.3094).
Withalongolide M (13): [α]25D −4.4 (c 0.08, MeOH); IR (neat)
νmax 3380 (br), 2932 (br), 1687, 1650, 1388, 1070 cm
−1; 1H NMR and
13C NMR, see Tables 4 and 5; ESIMS (positive-ion mode) m/z 1209
(2 M + H, 20), 1048 (2 M − glc + H, 30), 622 (M + H2O, 30), 605
(M + H, 10), 443 (M − glc + H, 100); HRESIMS m/z 627.3156 [M +
Na]+ (calcd for C33H48O10Na, 627.3145).
Withalongolide N (14): [α]25D −2.0 (c 0.14, MeOH); IR (neat)
νmax 3368 (br), 2931 (br), 1688, 1650, 1384, 1072, 1017 cm
−1; 1H
NMR and 13C NMR, see Tables 4 and 5; ESIMS (positive-ion mode)
m/z 1209 (2 M + H, 35), 605 (M + H, 100); LC-MS/MS fragments of
m/z 1209 peak: m/z 605 (M + H, 100), 443 (M − glc + H, 100); LC-
MS/MS fragments of m/z 605 peak: m/z 443 (M − glc + H, 100);
HRESIMS m/z 627.3146 [M + Na]+ (calcd for C33H48O10Na,
627.3145).
Cytotoxicity Bioassay. The cytotoxicity assays were performed as
previously described.11 In general, five concentrations ranging from 0.1
to 100 μg/mL were tested for the extracts, and 10 concentrations
ranging from 50 nM to 20 μM were tested for pure compounds.
Statistical analysis was carried out by one-way ANOVA on ranks test
using GraphPad Prism 5 (GraphPad Software, San Diego, CA, USA).
IC50 values were obtained from cell viability plots fitted with a




1H and 13C NMR spectra of withanolides 1−21 and the
bioassay data of the samples (CH2Cl2−MeOH crude extract,
hexane-soluble fraction, EtOAc-soluble fraction, and n-BuOH-
soluble fraction) are available free of charge via the Internet at
http://pubs.acs.org. Crystallographic data for the structures of
1, 2, 3, and 6 reported in this paper have been deposited with
the Cambridge Crystallographic Data Centre, under reference
numbers CCDC 840311, CCDC 840312, CCDC 840313, and
CCDC 840314, respectively. Copies of the data can be
obtained, free of charge, on application to the Director,
CCDC, 12 Union Road, Cambridge CB2 1EZ, UK (fax: +44-
(0)1223-336033 or e-mail: deposit@ccdc.cam.ac.uk).
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